| abstract |
The present invention relates to novel binder drug conjugates (ADCs), active metabolites of such ADCs, methods for preparing such ADCs, uses of such ADCs for the treatment and/or prevention of diseases, and the use of such ADCs Use of a medicament for the treatment and/or prevention of a disease, in particular a hyperproliferative disorder and/or an angiogenic disorder, such as a cancer disorder. Such treatment can be performed as a monotherapy or in combination with other agents or other therapeutic measures. |